Correlation between biofilm formation and gelE, esp, and agg genes in enterococcus spp. clinical isolates

Virulence

Volumn 5, Issue 5, 2014, Pages

  Soares, Renata O ^a   Fedi, Ana Cláudia ^a   Reiter, Keli C ^a   Caierão, Juliana ^a   D'Azevedo, Pedro A ^a  

^a Federal School of Medical Sciences of Porto Alegre   (Brazil)

Author keywords

Agg; Biofilm; Enterococcus faecalis; Enterococcus faecium; Esp; gelE

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LINEZOLID; NITROFURANTOIN; QUINOLONE DERIVATIVE; VANCOMYCIN; VIRULENCE FACTOR; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ADOLESCENT; ADULT; AGED; AGG GENE; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; BIOFILM; CHILD; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESP GENE; FEMALE; GELE GENE; GENE; HUMAN; INFANT; LETTER; MAJOR CLINICAL STUDY; MALE; NEWBORN; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GRAM POSITIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; CHILD; CHILD, PRESCHOOL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84904015642     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.28998     Document Type: Letter

References (43)

1. Malani PN, Kauffman CA, Zervos MJ. Enterococcal disease, epidemioloy, and treatment. In: Gilmore MS. (ed). The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance, 1 ed. Washington, DC: American Society for Microbiology, 2002. 385-408.
2. Giridhara Upadhyaya PM, Umapathy BL, Ravikumar KL. Comparative study for the presence of enterococcal virulence factors gelatinase, hemo-lysin and biofilm among clinical and commensal isolates of enterococcus faecalis. J Lab Physicians 2010; 2:100-104; PMID:21346906; http://dx.doi.org/10.4103/0974-2727.72159
3. Kafil HS, Mobarez AM, Moghadam MF. Adhesion and virulence factor properties of Enterococci isolated from clinical samples in Iran. Indian J Pathol Microbiol 2013; 56:238-242; PMID: 24152500; http://dx.doi.org/10.4103/0377-4929.120375
4. Heikens E, Bonten MJ, Willems RJ. Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 2007; 189:8233-8240; PMID:17827282; http://dx.doi.org/10.1128/JB.01205-07
5. Hancock LE, Perego M. The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J Bacteriol 2004; 186:5629-5639; PMID: 15317 767; http://dx.doi.org/10.1128/JB.186.17.5629-5639.2004
6. Giridhara Upadhyaya PM, Ravikumar KL, Umapathy BL. Review of virulence factors of entero-coccus: an emerging nosocomial pathogen. Indian J Med Microbiol 2009; 27:301-305; PMID:19736397; http://dx.doi.org/10.4103/0255-0857.55437
7. Shankar V, Baghdayan AS, Huycke MM, Lindahl G, Gilmore MS. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun 1999; 67:193-200; PMID:9864215
8. Chuang-Smith ON, Wells CL, Henry-Stanley MJ, Dunny GM. Acceleration of Enterococcus faecalis biofilm formation by aggregation substance expression in an ex vivo model of cardiac valve colonization. PLoS One 2010; 5:e15798; PMID:21209892; http://dx.doi.org/10.1371/journal.pone.0015798
9. Gilmore MS, Coburn PS, Nallapareddy SR, Murray BE. Enterococcal Virulence. In: Gilmore MS. (ed). The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance, 1 ed. Washington, DC: American Society for Microbiology, 2002. 301-354.
10. Koch S, Hufnagel M, Theilacker C, Huebner J. Enterococcal infections: host response, therapeutic, and prophylactic possibilities. Vaccine 2004; 22:822-830; PMID:15040934; http://dx.doi.org/10.1016/j.vaccine.2003.11.027
11. Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology 2009; 155:1749-1757; PMID:19383684; http://dx.doi.org/10.1099/mic.0.026385-0
12. Tenke P, Köves B, Nagy K, Hultgren SJ, Mendling W, Wullt B, Grabe M, Wagenlehner FM, Cek M, Pickard R, et al. Update on biofilm infections in the urinary tract. World J Urol 2012; 30:51-57; PMID:21590469; http://dx.doi.org/10.1007/s00345-011-0689-9
13. Mohamed JA, Huang DB. Biofilm formation by enterococci. J Med Microbiol 2007; 56:1581-1588; PMID:18033823; http://dx.doi.org/10.1099/jmm.0.47331-0
14. Almohamad S, Somarajan SR, Singh KV, Nallapareddy SR, Murray BE. Influence of isolate origin and presence of various genes on biofilm formation by Enterococcus faecium. FEMS Microbiol Lett 2014; 353:151-156, 6; PMID:24606170; http://dx.doi.org/10.1111/1574-6968.12418
15. d'Azevedo PA, Dias CA, Teixeira LM. Genetic diversity and antimicrobial resistance of entero-coccal isolates from Southern region of Brazil. Rev Inst Med Trop Sao Paulo 2006; 48:11-16; PMID:16547573; http://dx.doi.org/10.1590/S0036-46652006000100003
16. nd, Moraes LM, Boelens H, Van Belkum A, et al. Molecular epidemiology and antimicrobial susceptibility of Enterococci recovered from Brazilian intensive care units. Braz J Infect Dis 2004; 8:197-205; PMID: 15476051; http://dx.doi.org/10.1590/S1413-86702004000300002
17. Bender EA, de Freitas AL, Reiter KC, Lutz L, Barth AL. Identification, antimicrobial resistance and geno-typic characterization of Enterococcus spp. isolated in Porto Alegre, Brazil. Braz J Microbiol 2009; 40:693-700; PMID:24031416; http://dx.doi.org/10.1590/S1517-83822009000300035
18. Conceição N, Oliveira Cda C, Silva PR, Avila BG, Oliveira AG. Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study. Rev Soc Bras Med Trop 2011; 44:177-181; PMID:21468473; http://dx.doi.org/10.1590/S0037-86822011005000009
19. Parameswarappa J, Basavaraj V P, Basavaraj CM. Isolation, identification, and antibiogram of enterococci isolated from patients with urinary tract infection. Ann Afr Med 2013; 12:176-181; PMID:24005591; http://dx.doi.org/10.4103/1596-3519.117629
20. Sharifi Y, Hasani A, Ghotaslou R, Naghili B, Aghazadeh M, Milani M, Bazmany A. Virulence and antimicrobial resistance in enterococci isolated from urinary tract infections. Adv Pharm Bull 2013; 3:197-201; PMID:24312835
21. Fernandes SC, Dhanashree B. Drug resistance & virulence determinants in clinical isolates of Enterococcus species. Indian J Med Res 2013; 137:981-985; PMID:23760387
22. Swaminathan S, Alangaden GJ. Treatment of resistant enterococcal urinary tract infections. Curr Infect Dis Rep 2010; 12:455-464; PMID:21308555; http://dx.doi.org/10.1007/s11908-010-0138-8
23. Lee G. Ciprofloxacin resistance in Enterococcus fae-calis strains isolated from male patients whit complicated urinary tract infection. Korean J Urol 2013; 54:388-393; PMID:23789048; http://dx.doi.org/10.4111/kju.2013.54.6.388
24. Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJM. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11: 821-828; PMID: 15963275; http://dx.doi.org/10.3201/1106.041204
25. Johansson D, Rasmussen M. Virulence factors in isolates of Enterococcus faecalis from infective endocarditis and from the normal flora. Microb Pathog 2013; 55:28-31; PMID:23044056; http://dx.doi.org/10.1016/j.micpath.2012.09.009
26. Di Rosa R, Creti R, Venditti M, D'Amelio R, Arciola CR, Montanaro L, Baldassarri L. Relationship between biofilm formation, the enterococcal surface protein (Esp) and gelatin-ase in clinical isolates of Enterococcus faecalis and Enterococcus faecium. FEMS Microbiol Lett 20 06; 256:145-150; PMID:16487332; http://dx.doi.org/10.1111/j.1574-6968.2006.0011 2.x
27. Hällgren A, Claesson C, Saeedi B, Monstein HJ, Hanberger H, Nilsson LE. Molecular detection of aggregation substance, enterococcal surface protein, and cytolysin genes and in vitro adhesion to urinary catheters of Enterococcus faecalis and E. faecium of clinical origin. Int J Med Microbiol 2009; 299:323-332; PMID:19042153; http://dx.doi.org/10.1016/j. ijmm.2008.10.001
28. Comerlato CB, de Resende MC, Caierão J, d'Azevedo PA. Presence of virulence factors in Enterococcus fae-calis and Enterococcus faecium susceptible and resistant to vancomycin. Mem Inst Oswaldo Cruz 2013; 108:590-595; PMID:23903974; http://dx.doi.org/10.1590/S0074-02762013000500009
29. Panesso D, Reyes J, Rincón S, Díaz L, Galloway-Peña J, Zurita J, Carrillo C, Merentes A, Guzmán M, Adachi JA, et al. Molecular epidemiology of vanco-mycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals. J Clin Microbiol 2010; 48:1562-1569; PMID:20220167; http://dx.doi.org/10.1128/JCM.02526-09
30. Nallapareddy SR, Weinstock GM, Murray BE. Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol 2003; 47:1733-1747; PMID:12622825; http://dx.doi.org/10.1046/j.1365-2958.2003.03417.x
31. Koch S, Hufnagel M, Theilacker C, Huebner J. Enterococcal infections: host response, therapeutic, and prophylactic possibilities. Vaccine 2004; 22:822-830; PMID:15040934; http://dx.doi.org/10.1016/j. vaccine.2003.11.027
32. Van Tyne D, Martin MJ, Gilmore MS. Structure, function, and biology of the Enterococcus fae-calis cytolysin. Toxins (Basel) 2013; 5:895-911; PMID:23628786; http://dx.doi.org/10.3390/toxins5050895
33. Schlüter S, Franz CM, Gesellchen F, Bertinetti O, Herberg FW, Schmidt FR. The high biofilm-encoding Bee locus: a second pilus gene cluster in Enterococcus faecalis? Curr Microbiol 2009; 59:206-211; PMID: 19459002; http://dx.doi.org/10.1007/s00284-009-9422-y
34. Nallapareddy SR, Singh K V, Sillanpää J, Garsin DA, Höök M, Erlandsen SL, Murray BE. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J Clin Invest 2006; 116:2799-2807; PMID:17016560; http://dx.doi.org/10.1172/JCI29021
35. Jahan M, Holley RA. Incidence of virulence factors in enterococci from raw and fermented meat and biofilm forming capacity at 25°C and 37°C. Int J Food Microbiol 2014; 170:65-69; PMID:24291183; http://dx.doi.org/10.1016/j.ijfoodmicro.2013.11.002
36. Teixeira LM, Carvalho MGS, Shewmaker PL, Facklam RR. Enterococcus. In: Versalovic, J.; Carrol, K.C.; Funke, G.; Jorgensen, J.H.; Landry, M.L.; Warnock, D.W. Manual of Clinical Microbiology, 10th ed., v. 1, American Society for Microbiology, Washington, DC. 2011, 350-364.
37. Kariyama R, Mitsuhata R, Chow JW, Clewell DB, Kumon H. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol 2000; 38:3092-3095; PMID:10921985
38. Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 2001; 67:1628-1635; PMID:11282615; http://dx.doi.org/10.1128/AEM.67.4.1628-1635.2001
39. Creti R, Imperi M, Bertuccini L, Fabretti F, Orefici G, Di Rosa R, Baldassarri L. Survey for virulence determinants among Enterococcus faecalis isolated from different sources. J Med Microbiol 2004; 53:13-20; PMID:14663100; http://dx.doi.org/10.1099/jmm.0.05353-0
40. Marra A, Dib-Hajj F, Lamb L, Kaczmarek F, Shang W, Beckius G, Milici AJ, Medina I, Gootz TD. Enterococcal virulence determinants may be involved in resistance to clinical therapy. Diagn Microbiol Infect Dis 2007; 58:59-65; PMID:17300898; http://dx.doi.org/10.1016/j.diagmicrobio.2006.11.024
41. Clinical and Laboratory Standards Institute (CLSI). (2013). Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement M100-S23. Wayne, PA.
42. Magiorakos A P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-281; PMID:21793988; http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x
43. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000; 40:175-179; PMID:10699673; http://dx.doi.org/10.1016/S0167-7012(00)00122-6